Research Review: Multiple Myeloma – Issue 22

Issue 22 of Multiple Myeloma Research Review.

Highlights include:

•   Benefits of low dose lenalidomide in relapsed/refractory MM.

•   Network meta-analysis: treatment outcomes in relapsed/refractory MM.

•   Improved outcomes for patients treated a speciality MM clinics.

•   Real world benefits of bortezomib regimens for non-transplant eligible MM.

Download here